Subscribe To
Clearside Biomedical Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Duration of Effect in Data Presentation at the American Society of Retina Specialists 41st Annual Scientif
– Suprachoroidal Injection of CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months – ALPHARETTA, Ga., July 31, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that safety and tolerability […] The post Clearside Biomedical Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Du...
Read More
Posted: Jul 31 2023, 11:05
Author Name: forextv
Views: 080881